Nanosphere (NSPH) Significant Revenue Growth; Zumiez (ZUMZ) Above-Consensus Projections


Shares of Nanosphere, Inc. (Nasdaq:NSPH) soared more than 40% in the extended session Wednesday after the company delivered a significant revenue growth in its preliminary quarterly financial results

Nanosphere posted – preliminary – fourth quarter 2015 revenue of $6.8 million, a 48% increase versus  the same quarter the prior year, and revenue of $21.0 million for the full year 2015, surpassing its revenue guidance range of $18 million to $20 million for the period and representing almost 47% increase year over year

NSPH stock closed at $0.58, down $0.01 (or -1.69%), and 91,577 of its shares exchanged hands during the day

Nanosphere, a company enhancing medicine through targeted molecular diagnostics, has 10.53M Shares Outstanding, Market Capitalization (intraday) of $6.11M and NSPH stock 52-week range is from $0.48 to $9.00 per share



Zumiez Inc. (Nasdaq:ZUMZ) stock climbed over 10% in after-hours trading Wednesday as the company boosted its guidance as a result of better-than-expected sales

For its fourth quarter fiscal 2015, Zumiez now expects revenue to be in a range of $237 million to $239 million, compared to the previously reported revenue guidance range of $226 million to $231 million and exceeding the Capital IQ Consensus Estimate of $230.33 million in revenues for the period

ZUMZ shares finished the regular session at $15.08, down $0.23 (or -1.50%)

Zumiez, a leading specialty retailer of apparel, footwear, accessories and hardgoods, has 26.69M Shares Outstanding, Market Capitalization (intraday) of $402.42M and ZUMZ stock one-year range is between $11.53 and $41.81 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at